PRECISESADS General Assembly
The next PRECISESADS project meeting will take place on the 8th – 9th of March, 2018 in Ascot, UK. AGENDA you can register for this event at https://www.surveymonkey.com/r/RWDBLRS
-
Welcome to PRECISESADS
PRECISESADS is an EU project formed by 21 academic, 2 SMEs and 5 industrial partners from 12 countries spread right across Europe, planned for 5 years with a budg...Read more -
UPDATE! News & Events
IV European Conference “Genomics of Complex Diseases: New Challenges”,Read more
Granada, Spain, October 4-5, 2018. Registration deadline: 10th of Sept. 2018
-
PRECISESADS Partner profile
CING The Cyprus Institute of Neurology and Genetics (CING), was established in 1990. The Vision of CING is to function as an International Centre of Excellence.Read more
About PRECISESADS
Inflammatory autoimmune diseases such as rheumatoid arthritis and lupus affect 1-3% of the population, and while treatments exist, these are costly and have a number of serious side effects. There is growing evidence that many of these conditions may be incorrectly classified. The PRECISESADS project will study 2 500 people with various autoimmune diseases, gathering data on the molecular causes of their disease as well as their clinical symptoms. Using this information, they will pave the way for a new classification of these diseases, something that will allow doctors to offer patients more personalised treatments at an earlier stage of their disease.
Latest Project News
-
-
25 JAN 18
- 0
-
-
-
13 NOV 17
- 0
Patient recruitment completed
“We are delighted to report that we have over-achieved our recruitment targets for this project. Patient recruitment can be especially difficult as patients are widely dispersed and may face issues, such as physical limitations, that can affect their ability to readily participate” says Prof Alarcón Riquelme. ‘Patients have been highly motivated and generously willing to
-
Events
-
-
04/10/2018GRANADA
IV European Conference “Genomics of Complex Diseases: New Challenges”
IV European Conference: “Genomics of Complex Diseases: New Challenges” Granada, Spain, October 4-5, 2018 Welcome The PRECISESADS Project…
-
-
-
07/03/2018Ascot, UK
PRECISESADS General Assembly
The next PRECISESADS project meeting will take place on the 8th – 9th of March, 2018 in Ascot, UK. (AGENDA)…
-
-
-
26/11/2017Cancun
LACA 2017
"Novel Therapies in Autoimmune Diseases" LACA 2017, the 5th Latin American Congress on Autoimmunity will be held in the serene…
-
-
Information for Patients & Patients Associations
General information, list of patients associations, …
-
UCB
UCB Pharma S.A.
(EFPIA member company) -
FPS
Fundación Pública Andaluza Progreso y Salud (GENYO)
-
Althia
Althia Health, S.L.
(SME) -
CHP
Centro Hospitalar do Porto. UMIB
-
CSIC
Consejo Superior de Investigaciones Científicas
-
IRCCS
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
-
IDIBELL
Fundacio Institut D'investigacio Biomedica De Bellvitge
-
SCS
Servicio Cantabro de Salud Hospital Universitario Marqués de Valdecilla
-
IDIBAPS
Consorci Institut d’Investigacions Biomèdiques August Pi i Sunyer
-
KI
Karolinska Institute
-
K.U.LEUVEN
Katholieke Universiteit Leuven
-
UKK
Klinikum Der Universitaet Zu Koeln
-
MHH
Medizinische Hochschule Hannover
-
MUW
Medizinische Universitat Wien
-
QBIO
Quartz Bio
-
SAS
Servicio Andaluz de Salud
-
CING
The Cyprus Foundation for Muscular Dystrophy Research
-
UGR
Universidad de Granada
-
UNIMI
Università degli studi di Milano
-
UCL
Université catholique de Louvain
-
UBO
Université de Bretagne Occidentale
-
UNIGE
University of Geneva
-
USZ
University of Szeged
-
DRFZ
Deutsches Rheuma-Forschungszentrum Berlin
-
BAYER
BAYER Pharma AG
(EFPIA member company) -
I.R.I.S.
Institut de Recherches Internationales Servier
(EFPIA member company) -
SARD
Sanofi-Aventis Research and Development (EFPIA member company)
-
Lilly
Eli Lilly and Company
(EFPIA member company)